Virtual Library

Start Your Search

C. Chen



Author of

  • +

    P2.04 - Poster Session/ Biology, Pathology, and Molecular Testing (ID 234)

    • Event: WCLC 2015
    • Type: Poster
    • Track: Biology, Pathology, and Molecular Testing
    • Presentations: 1
    • +

      P2.04-106 - Expression of AEG-1 Associated with Increase of TS Contributes to Chemoresistance of Pemetrexed in Lung Adenocarcinoma (ID 668)

      09:30 - 09:30  |  Author(s): C. Chen

      • Abstract
      • Slides

      Background:
      Previous studies have suggested that astrocyte-elevated gene-1 (AEG‑1) contributes to a broad spectrum of resistance to various chemotherapeutics. Expression of thymidylate synthase (TS) has implication for effectiveness of pemetrexed in treatment of lung cancer. In this study, we investigated the AEG-1 activity to determine whether its expression is correlated with TS increasing resulted in chemoresistance of pemetrexed in patients with advanced lung adenocarcinoma.

      Methods:
      Patients with advanced lung adenocarcinoma treated with pemetrexed plus cisplatin as first-line chemotherapy were enrolled. Re-biopsy was performed until disease progression. Immunohistochemical stain of AEG-1 and TS were studied in all patients' tissue before chemotherapy and after disease progression. The primary antibodies used were anti-AEG-1 (1:1,000; chicken polyclonal), anti-actin (1:1,000; rabbit polyclonal; Santa Cruz), and anti-TS (1:1,000; mouse monoclonal; Abcam). The expression of TS and AEG-1 were calculated by H-score. The medical records were reviewed and analyzed, including data on age, gender, smoking status, epidermal growth factor receptor (EGFR) mutation status, treatment responses, and survival.

      Results:
      A total of six patients (3 male and 3 female) received first-line chemotherapy as pemetrexed/cisplatin for 6 cycles and continuation maintenance therapy with pemetrexed. The mean age was 57.2 years old. Overall best treatment response were partial response. The median of progression-free survival was 5.8 months. Re-biopsy was performed in all of them after disease progression. The expression of AEG-1 level increased from baseline to disease progression (mean, AEG-1, 133.3 to 175.0, p = 0.001), associated with elevation of TS level (mean, TS, 57.9 to 116,1, p = 0.01).

      Conclusion:
      Expression of AEG-1 associated with increase of TS contributes to chemoresistance of pemetrexed in lung adenocarcinoma. TS expression might be regulated by AEG-1 associated with development of chemoresistance to pemetrexed.

      Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.